Annual CFI
-$107.20 M
-$114.90 M-1492.21%
31 December 2023
Summary:
Mirum Pharmaceuticals annual cash flow from investing activities is currently -$107.20 million, with the most recent change of -$114.90 million (-1492.21%) on 31 December 2023. During the last 3 years, it has fallen by -$155.75 million (-320.82%). MIRM annual CFI is now -320.82% below its all-time high of $48.55 million, reached on 31 December 2021.MIRM Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFI
-$18.04 M
+$54.68 M+75.20%
30 September 2024
Summary:
Mirum Pharmaceuticals quarterly cash flow from investing activities is currently -$18.04 million, with the most recent change of +$54.68 million (+75.20%) on 30 September 2024. Over the past year, it has dropped by -$16.04 million (-801.80%). MIRM quarterly CFI is now -116.70% below its all-time high of $108.02 million, reached on 31 December 2021.MIRM Quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFI
-$92.77 M
+$164.73 M+63.97%
30 September 2024
Summary:
Mirum Pharmaceuticals TTM cash flow from investing activities is currently -$92.77 million, with the most recent change of +$164.73 million (+63.97%) on 30 September 2024. Over the past year, it has increased by +$14.43 million (+13.46%). MIRM TTM CFI is now -155.80% below its all-time high of $166.26 million, reached on 30 June 2022.MIRM TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
MIRM Cash From Investing Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | -801.8% | +13.5% |
| 3 y3 years | -320.8% | -116.7% | -291.1% |
| 5 y5 years | +16.1% | -250.6% | +27.4% |
MIRM Cash From Investing High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -320.8% | at low | -116.7% | +90.1% | -155.8% | +64.0% |
| 5 y | 5 years | -320.8% | +16.1% | -116.7% | +90.1% | -155.8% | +64.0% |
| alltime | all time | -320.8% | +16.1% | -116.7% | +90.1% | -155.8% | +64.0% |
Mirum Pharmaceuticals Cash From Investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$18.04 M(-75.2%) | -$92.77 M(-64.0%) |
| June 2024 | - | -$72.72 M(>+9900.0%) | -$257.49 M(+91.8%) |
| Mar 2024 | - | -$13.00 K(-99.4%) | -$134.23 M(+25.2%) |
| Dec 2023 | -$107.20 M(-1492.2%) | -$2.00 M(-98.9%) | -$107.20 M(+36.7%) |
| Sept 2023 | - | -$182.76 M(-461.6%) | -$78.44 M(-416.4%) |
| June 2023 | - | $50.55 M(+87.1%) | $24.79 M(-1488.9%) |
| Mar 2023 | - | $27.02 M(+1.0%) | -$1.78 M(-123.2%) |
| Dec 2022 | $7.70 M(-84.1%) | $26.76 M(-133.6%) | $7.70 M(-91.3%) |
| Sept 2022 | - | -$79.53 M(-431.8%) | $88.97 M(-46.5%) |
| June 2022 | - | $23.97 M(-34.3%) | $166.26 M(+41.1%) |
| Mar 2022 | - | $36.50 M(-66.2%) | $117.83 M(+142.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2021 | $48.55 M(+28.2%) | $108.02 M(-4928.9%) | $48.55 M(-175.4%) |
| Sept 2021 | - | -$2.24 M(-90.9%) | -$64.42 M(-20.6%) |
| June 2021 | - | -$24.45 M(-25.4%) | -$81.10 M(+182.9%) |
| Mar 2021 | - | -$32.78 M(+562.8%) | -$28.67 M(-175.7%) |
| Dec 2020 | $37.87 M(-129.6%) | -$4.95 M(-73.9%) | $37.87 M(+0.5%) |
| Sept 2020 | - | -$18.91 M(-167.6%) | $37.68 M(-595.6%) |
| June 2020 | - | $27.97 M(-17.1%) | -$7.60 M(-91.9%) |
| Mar 2020 | - | $33.76 M(-756.3%) | -$93.98 M(-26.5%) |
| Dec 2019 | -$127.78 M | -$5.14 M(-92.0%) | -$127.78 M(+4.2%) |
| Sept 2019 | - | -$64.19 M(+9.9%) | -$122.64 M(+109.8%) |
| June 2019 | - | -$58.40 M(>+9900.0%) | -$58.45 M(>+9900.0%) |
| Mar 2019 | - | -$44.00 K | -$44.00 K |
FAQ
- What is Mirum Pharmaceuticals annual cash flow from investing activities?
- What is the all time high annual CFI for Mirum Pharmaceuticals?
- What is Mirum Pharmaceuticals quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for Mirum Pharmaceuticals?
- What is Mirum Pharmaceuticals quarterly CFI year-on-year change?
- What is Mirum Pharmaceuticals TTM cash flow from investing activities?
- What is the all time high TTM CFI for Mirum Pharmaceuticals?
- What is Mirum Pharmaceuticals TTM CFI year-on-year change?
What is Mirum Pharmaceuticals annual cash flow from investing activities?
The current annual CFI of MIRM is -$107.20 M
What is the all time high annual CFI for Mirum Pharmaceuticals?
Mirum Pharmaceuticals all-time high annual cash flow from investing activities is $48.55 M
What is Mirum Pharmaceuticals quarterly cash flow from investing activities?
The current quarterly CFI of MIRM is -$18.04 M
What is the all time high quarterly CFI for Mirum Pharmaceuticals?
Mirum Pharmaceuticals all-time high quarterly cash flow from investing activities is $108.02 M
What is Mirum Pharmaceuticals quarterly CFI year-on-year change?
Over the past year, MIRM quarterly cash flow from investing activities has changed by -$16.04 M (-801.80%)
What is Mirum Pharmaceuticals TTM cash flow from investing activities?
The current TTM CFI of MIRM is -$92.77 M
What is the all time high TTM CFI for Mirum Pharmaceuticals?
Mirum Pharmaceuticals all-time high TTM cash flow from investing activities is $166.26 M
What is Mirum Pharmaceuticals TTM CFI year-on-year change?
Over the past year, MIRM TTM cash flow from investing activities has changed by +$14.43 M (+13.46%)